SCHEMBL4732717

SCHEMBL4732717

COC(=O)c1cccc(C(C)=O)c1NC(=O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 5/20 0.49
LMNA P02545 4/20 0.44
HPGD P15428 1/20 0.43
TSHR P16473 2/20 0.43
F2R P25116 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 2/20 0.41
CFTR P13569 1/20 0.41
ATM Q13315 2/20 0.40
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
MTNR1B P49286 2/20 0.40
STAT3 P40763 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28429236 0.83 F2R (0.51) ALDH1A1KDM4ELMNAHPGDTSHR
SCHEMBL4732713 0.79 KDM4E (0.54) ALDH1A1KDM4ELMNAHPGDTSHR
SCHEMBL5928724 0.76 TSHR (0.68) ALDH1A1KDM4ELMNAHPGDTSHR
SCHEMBL2624140 0.73 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHPGDTSHR
SCHEMBL10397861 0.72 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL1956734 0.72 LMNA (0.63) ALDH1A1KDM4ELMNATSHRKMT2A
SCHEMBL24963554 0.71 KMT2A (0.51) ALDH1A1KDM4EHPGDTSHRHTT
SCHEMBL2148841 0.71 LMNA (0.57) ALDH1A1KDM4ELMNATSHRKMT2A
SCHEMBL16953017 0.71 LMNA (0.52) ALDH1A1KDM4ELMNATSHRKMT2A
SCHEMBL28769090 0.70 CA1 (0.59) ALDH1A1KDM4ELMNATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008054454-A2 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF AS ANTIVIRAL AGENTS TRANSTECH PHARMA, INC. (US) 2008-05-08 WO disclosed